MPM BioVentures 2014
Venture capitalCambridge · 4 people tracked
Find your way into MPM BioVentures 2014
Fund manager profile
MPM BioVentures 2014 is a venture fund manager based in Cambridge. SEC filings show 1 venture fund on record, most recently MPM BioVentures 2014, L.P. ($347.3M offering) filed July 2015.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 4 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathAligos is a clinical-stage biotechnology company developing therapeutics for liver and viral diseases, including chronic hepatitis B virus (HBV) infection and MASLD/MASH.
BiotechHealthtechSouth San Francisco, US
Leonid Beigelman(President)inLawrence M. Blatt(Chairman, President & CEO (Co-founder))inHardean Achneck(Executive Officer)inBrian Dowd(Executive Vice President - Controller)inLucinda Quan(Executive Vice President - General Counsel)inJulian Symons(Executive Vice President, Chief Scientific Officer)in
Board seatJames Scopa· per SEC Form D · $92.2M raise · filed Nov 2023
Co-investorsRoche Venture FundVivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companiesAligos Therapeutics · rttnews.com · Aug 10, 2026
Frequently asked questions
- Where is MPM BioVentures 2014 located?
- MPM BioVentures 2014 is headquartered in Cambridge, US.